Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses

An isolated nucleic acid molecule selected from the group consisting of:

• a) a nucleic acid molecule having a nucleotide sequence which is at least 90% identical to the nucleotide sequence of any of SEQ ID NOs:
• 1, 2, 11, 12, 21, 22, 31, 32, 41, 42, 51, 52, 61, 62, 71, 72, 81, 82, and the nucleotide sequence of any of the clones deposited as ATCC® Accession numbers 207185, 207221, PTA-147, PTA-425, PTA-424, ______, and ______, or a complement thereof;
• b) a nucleic acid molecule comprising at least 15 nucleotide residues and having a nucleotide sequence identical to at least 15 consecutive nucleotide residues of any of SEQ ID NOs:
• 1, 2, 11, 12, 21, 22, 31, 32, 41, 42, 51, 52, 61, 62, 71, 72, 81, 82, and the nucleotide sequence of any of the clones deposited as ATCC® Accession numbers 207185, 207221, PTA-147, PTA-425, PTA-424, ______, and ______, or a complement thereof;
• c) a nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence of any of SEQ ID NOs:
• 3-8, 13-18, 23-28, 33-38, 43, 53-55, 63-65, 73, and 83-85, and the amino acid sequence encoded by the nucleotide sequence of any of the clones deposited as ATCC® Accession numbers 207185, 207221, PTA-147, PTA-425, PTA-424, ______, and ______;
• d) a nucleic acid molecule which encodes a fragment of a polypeptide comprising the amino acid sequence of any of SEQ ID NOs:
• 3-8, 13-18, 23-28, 33-38, 43, 53-55, 63-65, 73, and 83-85 and the amino acid sequence encoded by the nucleotide sequence of any of the clones deposited as ATCC® Accession numbers 207185, 207221, PTA-147, PTA-425, PTA-424, ______, and ______, wherein the fragment comprises at least 10 consecutive amino acid residues of any of SEQ ID NOs:
• 3-8, 13-18, 23-28, 33-38, 43, 53-55, 63-65, 73, and 83-85 and the amino acid sequence encoded by the nucleotide sequence of any of the clones deposited as ATCC® Accession numbers 207185, 207221, PTA-147, PTA-425, PTA-424, ______, and ______;
• e) a nucleic acid molecule which encodes a fragment of a polypeptide comprising the amino acid sequence of any of SEQ ID NOs:
• 3-8, 13-18, 23-28, 33-38, 43, 53-55, 63-65, 73, and 83-85 and the amino acid sequence encoded by the nucleotide sequence of any of the clones deposited as ATCC® Accession numbers 207185, 207221, PTA-147, PTA-425, PTA-424, ______, and ______, wherein the fragment comprises consecutive amino acid residues corresponding to at least half of the full length of any of SEQ ID NOs:
• 3, 13, 23, 33, 43, 53, 63, 73, and 83 and the amino acid sequence encoded by the nucleotide sequence of any of the clones deposited as ATCC® Accession numbers 207185, 207221, PTA-147, PTA-425, PTA-424, ______, and ______;
• and
• f) a nucleic acid molecule which encodes a naturally occurring allelic variant of a polypeptide comprising the amino acid sequence of any of SEQ ID NOs:
• 3-8, 13-18, 23-28, 33-38, 43, 53-55, 63-65, 73, and 83-85, wherein the nucleic acid molecule hybridizes with a nucleic acid molecule consisting of the nucleotide sequence of any of SEQ ID NOs:
• 1, 2, 11, 12, 21, 22, 31, 32, 41, 42, 51, 52, 61, 62, 71, 72, 81, 82, and the nucleotide sequence of any of the clones deposited as ATCC® Accession numbers 207185, 207221, PTA-147, PTA-425, PTA-424, ______, and ______, or a complement thereof under stringent conditions.